Surveillance with dual noninvasive testing for acute cellular rejection after heart transplantation: Outcomes from the Surveillance HeartCare Outcomes Registry.
Kiran KhushShelley HallAndrew KaoNirav RavalRavi DhingraPalak ShahLavanya BellumkondaAshwin RavichandranAdrian Van BakelNir UrielSnehal PatelSean PinneyEugene DePasqualeDavid A BaranKevin PinneyKris OreschakJeremy KobulnikLing ShenJeffrey TeutebergPublished in: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (2024)
Dual molecular testing demonstrated improved performance for ACR surveillance compared to single molecular testing. The use of dual noninvasive testing was associated with lower biopsy rates over time, excellent survival, and low incidence of graft dysfunction.